 CAMBRIDGE, Mass., May 10, 2021 GLOBE NEWSWIRE -- Sigilon Therapeutics, Inc. NASDAQ:SGTX, a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living TherapeuticsTM platform, today reported financial results for the first quarter ended March 31, 2021 as well as certain other business highlights. 